Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.8200 (-3.31%) ($23.7850 - $23.8200) on Wed. Sep. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.17% (three month average) | RSI | 52 | Latest Price | $23.8200(-3.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.6% a day on average for past five trading days. | Weekly Trend | IOVA advances 3.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) IWO(40%) XBI(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.585% in a week (0% probabilities). VIXM(-24%) UUP(-15%) VXX(-11%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.585% (StdDev 3.17%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $24.1 | 5 Day Moving Average | $24.76(-3.8%) | 10 Day Moving Average | $24.53(-2.89%) | 20 Day Moving Average | $24.1(-1.16%) | To recent high | -10.6% | To recent low | 16.1% | Market Cap | $3.488b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |